2022 Update on Prostate Cancer Epidemiology and Risk Factors—A Systematic Review

Prostate cancer remains the second most common cancer among men. Screening is gaining acceptance, likely reducing mortality at the cost of overdiagnosis and overtreatment. Increasing use of magnetic resonance imaging and biomarkers may mitigate some of the negative consequences of screening. Prostat...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	European urology Ročník 84; číslo 2; s. 191 - 206
Hlavní autori:	Bergengren, Oskar, Pekala, Kelly R., Matsoukas, Konstantina, Fainberg, Jonathan, Mungovan, Sean F., Bratt, Ola, Bray, Freddie, Brawley, Otis, Luckenbaugh, Amy N., Mucci, Lorelei, Morgan, Todd M., Carlsson, Sigrid V.
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	Switzerland Elsevier B.V 01.08.2023
Predmet:	Epidemiology Humans Male Nephrology Njurmedicin Prostate - pathology Prostate cancer Prostate-Specific Antigen Prostatic Neoplasms - diagnosis Prostatic Neoplasms - epidemiology Prostatic Neoplasms - pathology Retrospective Studies Risk Factors Screening Screening Prostate cancer Epidemiology Risk factors
ISSN:	0302-2838, 1873-7560, 1873-7560
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!